The sequences are from the cancer trials. We know from one of the patients that they were doing genetic testing so it might be genomic sequencing. This is for applying for a breakthrough designation in cancer so it's not absolutely critical now. At worst if it is a payment issue, when we get revenue from an EUA we can pay it off get sequencing and apply for a BTD then.